Profil
James A. Vollins is currently the Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. Prior to this, he held the same position at BioDelivery Sciences International, Inc. from 2018 to 2022 and at Bio Products Laboratory Ltd. from 2014 to 2018.
Vollins received his undergraduate degree from Wesleyan University and his graduate degree from Case Western Reserve University School of Law.
Postes actifs de James Vollins
| Sociétés | Poste | Début |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Compliance Officer | 13/04/2023 |
Anciens postes connus de James Vollins
| Sociétés | Poste | Fin |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 22/03/2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. BiotechnologyHealth Technology Manufactures and supplies human blood plasma products | Compliance Officer | 01/10/2018 |
Formation de James Vollins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. BiotechnologyHealth Technology Manufactures and supplies human blood plasma products | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















